Company Description
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.
With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
As of June 30, 2025, Alexandria has a total market capitalization of $25.7 billion and an asset base in North America that includes 39.7 million RSF of operating properties and 4.4 million RSF of Class A/A+ properties undergoing construction and one 100% pre-leased committed near-term project expected to commence construction in the next year.
Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success.
Alexandria also provides strategic capital to transformative life science companies through our venture capital platform.
We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
| Country | United States |
| Founded | 1994 |
| IPO Date | May 27, 1997 |
| Industry | REIT - Office |
| Sector | Real Estate |
| Employees | 552 |
| CEO | Peter Moglia |
Contact Details
Address: 26 North Euclid Avenue Pasadena, California 91101-6104 United States | |
| Phone | 626 578 0777 |
| Website | are.com |
Stock Details
| Ticker Symbol | ARE |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001035443 |
| CUSIP Number | 015271109 |
| ISIN Number | US0152711091 |
| Employer ID | 95-4502084 |
| SIC Code | 6798 |
Key Executives
| Name | Position |
|---|---|
| Peter M. Moglia | Chief Executive Officer and Chief Investment Officer |
| Joel S. Marcus CPA, J.D. | Founder and Executive Chairman |
| Daniel J. Ryan | Co-President and Regional Market Director of San Diego |
| Hunter L. Kass | Co-President and Regional Market Director of Greater Boston |
| Joseph Hakman | Co-Chief Operating Officer and Chief Strategic Transactions Officer |
| Andres R. Gavinet CPA | Chief Accounting Officer |
| Gregory C. Thomas | Chief Technology Officer |
| Jackie B. Clem J.D. | General Counsel and Secretary |
| Dean A. Shigenaga CPA | Strategic Consultant |
| John J. Cox | Senior Vice President and Regional Market Director of Seattle |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 21, 2025 | 8-K | Current Report |
| Jul 21, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 21, 2025 | 10-Q | Quarterly Report |
| May 15, 2025 | 8-K | Current Report |
| Apr 28, 2025 | 8-K | Current Report |
| Apr 28, 2025 | 10-Q | Quarterly Report |
| Apr 2, 2025 | ARS | Filing |
| Apr 2, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 2, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 6, 2025 | 8-K | Current Report |